Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

US Patent 11820781 · Granted Nov 21, 2023

Estimated economic value: $5,095,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2025
Piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and2025
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses the2025
CBL inhibitors and compositions for use in adoptive cell therapy2024
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof2024
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2024
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway2024
Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof2022
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway2022
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2022
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses the2022
Methods of treating pulmonary hypertension2013